Leerink Partnrs Raises Earnings Estimates for Doximity

Doximity, Inc. (NASDAQ:DOCS) – Leerink Partnrs upped their FY2027 earnings per share (EPS) estimates for Doximity in a research report issued on Monday, March 3rd. Leerink Partnrs analyst M. Cherny now expects that the company will earn $1.33 per share for the year, up from their previous forecast of $1.31. Leerink Partnrs currently has a “Strong-Buy” rating on the stock. The consensus estimate for Doximity’s current full-year earnings is $0.99 per share. Leerink Partnrs also issued estimates for Doximity’s FY2028 earnings at $1.47 EPS.

Several other research analysts also recently weighed in on DOCS. Piper Sandler upgraded shares of Doximity from a “neutral” rating to an “overweight” rating and boosted their price target for the company from $31.00 to $78.00 in a report on Friday, February 7th. Barclays boosted their target price on shares of Doximity from $52.00 to $75.00 and gave the company an “overweight” rating in a research note on Monday, November 11th. Wells Fargo & Company reiterated an “equal weight” rating on shares of Doximity in a report on Friday, February 7th. Canaccord Genuity Group increased their price objective on Doximity from $60.00 to $71.00 and gave the stock a “hold” rating in a research note on Friday, February 7th. Finally, Needham & Company LLC lifted their target price on Doximity from $65.00 to $82.00 and gave the company a “buy” rating in a research note on Friday, February 7th. Eleven research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $64.22.

Doximity Trading Up 2.5 %

NASDAQ DOCS opened at $69.52 on Tuesday. Doximity has a 1 year low of $22.96 and a 1 year high of $85.21. The company has a market cap of $12.98 billion, a PE ratio of 69.52, a PEG ratio of 4.10 and a beta of 1.39. The stock’s 50-day moving average price is $62.53 and its two-hundred day moving average price is $51.31.

Insider Activity

In related news, Director Timothy S. Cabral sold 20,000 shares of the company’s stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the sale, the director now directly owns 6,360 shares in the company, valued at approximately $366,463.20. This represents a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 37.40% of the stock is owned by insiders.

Hedge Funds Weigh In On Doximity

Several institutional investors have recently bought and sold shares of the stock. Global Retirement Partners LLC increased its holdings in shares of Doximity by 468.1% during the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company’s stock valued at $29,000 after acquiring an additional 440 shares during the last quarter. UMB Bank n.a. boosted its position in Doximity by 69.1% during the fourth quarter. UMB Bank n.a. now owns 575 shares of the company’s stock worth $31,000 after purchasing an additional 235 shares during the period. Farther Finance Advisors LLC grew its holdings in Doximity by 324.2% during the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock valued at $34,000 after purchasing an additional 603 shares during the last quarter. Larson Financial Group LLC raised its position in shares of Doximity by 49.4% in the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company’s stock valued at $40,000 after purchasing an additional 250 shares during the period. Finally, Optimum Investment Advisors bought a new position in shares of Doximity in the fourth quarter valued at approximately $43,000. 87.19% of the stock is currently owned by institutional investors.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.